Infinity Pharmaceuticals Inc. (INFI) Down 8.54% in Premarket Trading

Monday, September 20, 2021 07:19 AM | InvestorsObserver Analysts

Mentioned in this article

Infinity Pharmaceuticals Inc. (INFI) Down 8.54% in Premarket Trading

Infinity Pharmaceuticals Inc. (INFI) is lower by Monday morning, with the stock decreasing -8.54% in pre-market trading to 3.32. INFI's short-term technical score of 79 indicates that the stock has traded more bullishly over the last month than 79% of stocks on the market. In the Biotechnology industry, which ranks 137 out of 146 industries, Infinity Pharmaceuticals Inc. ranks higher than 93% of stocks. Infinity Pharmaceuticals Inc. has risen 20.20% over the past month, closing at $3.20 on August 23. During this period of time, the stock fell as low as $3.20 and as high as $3.89. INFI has an average analyst recommendation of Strong Buy. The company has an average price target of $8.83.

INFI has an Overall Score of 86. Find out what this means to you and get the rest of the rankings on INFI!

See Full INFI Report

Infinity Pharmaceuticals Inc. has a Long-Term Technical rank of 96. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 4% of the market scoring higher. In the Biotechnology industry which is number 129 by this metric, INFI ranks better than 95% of stocks.

Important Dates for Investors in INFI:

-Infinity Pharmaceuticals Inc. is set to release earnings on 10/25/2021. During their last earnings release the company posted EPS of $-0.61. -We do not have a set dividend date for Infinity Pharmaceuticals Inc. at this time. Click Here To Get The Full Report on Infinity Pharmaceuticals Inc. (INFI)